Strides Arcolab, established in 1990, is into therapeutics including steroids, NSAIDS, herbal drugs, antibiotics and dosage form distribution including tablets, dry powder injection, capsules etc.
It has 13 plants in India, United States, Brazil, Mexico, Poland and Italy. Its Bangalore plant has a capacity of manufacturing 2.3 billion soft gelatin capsules, 1.275 billion hard gelatin capsules and 2.5 billion tablets. Its sterile product division manufactures parenterals in ampoules/vials and dry powder injections. This facility has a capacity for 22 million ampoules, 18 million vials and 15 million vials of dry powder p.a. The dedicated beta lactam plant manufactures 250 million hard gelatin capsules, 120 million tablets and 30 million dry powder injectables p.a.
Sterlite Acrolab is one of the largest soft gelatin manufacturers in the world. It envisages disposal of gelatin through common effluent treatment plant, which will reduce fuel and operating cost of localised disposal done presently. Its specialty chemical units at New Mangalore and Panoli manufacture a variety of APIs, intermediates for drugs, intermediates for fine and specialty chemicals as well as a variety of fine and specialty chemicals under secrecy agreements.
A variable frequency drive will be incorporated in a phased manner, which will consume less power for same torque required. It also has reverse osmosis reject water which is to be used for toilet flushing. The company plans to establish other areas of drug development including API research, non-infringing process development, bio-technology research and establish clinical research capability in-house. Strides Acrolab is headquartered at Bangalore, India.
Update
Strides Shasun Limited, formerly Strides Arcolab Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses. Its geographical segments are Africa, Australasia, North America and Europe, South and Central America, India and Others.
The Company focuses on developing complex pharmaceutical products across therapeutic segments. The Company's products include general tablets, hard gelatin capsules, soft gelatin capsules, sachets, dry powders, dry syrups, potent drugs, semi solids, ointments and creams. It is also involved in supplying generics to hospitals approved by the National Health Service (NHS) and over-the-counter (OTC) products through retail outlets. It operates approximately 10 facilities, which are diversified across Asia, Africa and Europe.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
